FTC and HHS launch probe of ongoing generic drug shortages
FTC and HHS launch probe of ongoing generic drug shortages
FTC and HHS launch probe of ongoing generic drug shortages
Published: Feb 14, 2024
By Tyler Patchen
BioSpace
With drug shortages in the U.S. not greatly improving, the Federal Trade Commission and the Department of Health and Human Services announced Wednesday that they are issuing a request for information to look at different groups involved in generic drug supply chains and evaluate how they may be contributing to persistent shortages.
The FTC and HHS are inviting public comments on market concentration and are gathering information on the contracting practices among wholesalers and group purchasing organizations (GPOs).
GPOs act as go middlemen between providers and manufacturers to negotiate the price of generic drugs. The request for information (RFI) also aims to determine the influence GPOs and wholesalers have on the overall generic drug availability and pricing.
“For years Americans have faced acute shortages of critical drugs, from chemotherapy to antibiotics, endangering patients,” FTC Chair Lina Khan said in a statement. “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen. We look forward to public input as we assess how enforcers and policymakers can best address chronic drug shortages and promote a resilient drug supply chain.”
The public has 60 days to submit comments to regulations.gov, where they will be posted publicly.
“Today’s announcement is part of the Biden-Harris Administration’s work to tackle health care monopolies and lessen the impact on vulnerable patients who bear the brunt of this lack of competition. Today’s initiative is just one more action by HHS to best address shortages of generic drugs,” HHS Secretary Xavier Becerra said in a statement.
The news from the FTC and HHS comes as a GAO report last week detailed how the FDA continues to encounter challenges in overseeing drug manufacturing sites overseas due to staff shortages and other factors. Experts on drug shortages recently told BioSpace that several factors, from manufacturing quality issues to factory closures to more systemic problems, have all contributed to shortages.
Tyler Patchen is a staff writer at BioSpace. You can reach him at [email protected]. Follow him on LinkedIn.
Source: BioSpace
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: